World's Best Scientists 2026 revealed!
Manlio Ferrarini

Manlio Ferrarini

D-Index & Metrics

Immunology

D-Index
68
Citations
21132
World Ranking
2560
National Ranking
100

Manlio Ferrarini publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Manlio Ferrarini sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 297 publications — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Manlio Ferrarini D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Manlio Ferrarini sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 68 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Manlio Ferrarini is affiliated with the University of Genoa in Italy. Their research spans several fields of medical science, focusing particularly on hematology and immunology.

The main fields of study for Ferrarini include:

  • Medicine
  • Immunology and Microbiology

Within these areas, subfields of study include:

  • Genetics
  • Immunology
  • Pathology and Forensic Medicine
  • Oncology
  • Molecular Biology

Ferrarini's research covers several main topics, such as:

  • Chronic Lymphocytic Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Immunodeficiency and Autoimmune Disorders
  • Cancer-related Molecular Pathways
  • Galectins and Cancer Biology
  • Advanced Breast Cancer Therapies
  • Chronic Myeloid Leukemia Treatments

Frequent publication venues where Ferrarini has contributed include:

  • Frontiers in Oncology (5 publications)
  • American Journal of Hematology (4 publications)
  • Haematologica (2 publications)
  • International Journal of Molecular Sciences (2 publications)
  • Hematological Oncology (2 publications)

Notable recent papers by Ferrarini and collaborators include:

  • International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia, 2020, Blood
  • Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter?, 2020, Frontiers in Oncology
  • Antitumor Effects of PRIMA-1 and PRIMA-1Met (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?, 2021, Cells
  • Chronic lymphocytic leukemia cells impair osteoblastogenesis and promote osteoclastogenesis: role of TNFα, IL-6 and IL-11 cytokines, 2020, Haematologica
  • Tracing CLL-biased stereotyped immunoglobulin gene rearrangements in normal B cell subsets using a high-throughput immunogenetic approach, 2020, Molecular Medicine

Ferrarini frequently collaborates with several coauthors, including:

  • Giovanna Cutrona
  • Antonino Neri
  • Fortunato Morabito
  • Franco Fais
  • Massimo Gentile

Best Publications

  • Chronic lymphocytic leukemia.

    Nicholas Chiorazzi;Kanti R. Rai;Manlio Ferrarini

  • Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.

    Franco Fais;Fabio Ghiotto;Shiori Hashimoto;Brian Sellars

  • In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells.

    Bradley T. Messmer;Davorka Messmer;Steven L. Allen;Steven L. Allen;Jonathan E. Kolitz;Jonathan E. Kolitz

  • B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes.

    Rajendra N. Damle;Fabio Ghiotto;Angelo Valetto;Emilia Albesiano

  • Expression of a receptor for IgM by human T cells in vitro.

    L. Moretta;M. Ferrarini;Maria Laura Durante;Maria Cristina Mingari

  • Subpopulations of Human T Cells Identified by Receptors for Immunoglobulins and Mitogen Responsiveness

    Lorenzo Moretta;Manlio Ferrarini;Maria C. Mingari;Alessandro Moretta

  • Multiple Distinct Sets of Stereotyped Antigen Receptors Indicate a Role for Antigen in Promoting Chronic Lymphocytic Leukemia

    Bradley T. Messmer;Emilia Albesiano;Dimitar G. Efremov;Fabio Ghiotto;Fabio Ghiotto

  • B Cell Chronic Lymphocytic Leukemia: Lessons Learned from Studies of the B Cell Antigen Receptor

    Nicholas Chiorazzi;Manlio Ferrarini

  • Receptors for IgG molecules on human lymphocytes forming spontaneous rosettes with sheep red cells.

    Ferrarini M;Moretta L;Abrile R;Durante Ml

  • Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities

    Nicholas Chiorazzi;Manlio Ferrarini

  • Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia

    Fabio Ghiotto;Franco Fais;Angelo Valetto;Emilia Albesiano

  • Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients.

    Monica Colombo;Mariella Dono;Paola Gazzola;Silvio Roncella

  • Effects in live cells of a c- myc anti-gene PNA linked to a nuclear localization signal

    Giovanna Cutrona;Elisabetta M. Carpaneto;Massimo Ulivi;Silvio Roncella

  • CD38 and chronic lymphocytic leukemia: a decade later

    Fabio Malavasi;Silvia Deaglio;Rajendra Damle;Giovanna Cutrona

  • CD38 Expression Distinguishes Two Groups of B-Cell Chronic Lymphocytic Leukemias With Different Responses to Anti-IgM Antibodies and Propensity to Apoptosis

    Simona Zupo;Laura Isnardi;Mauro Megna;Rosanna Massara

  • Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence

    Maria T. Di Martino;Emanuela Leone;Nicola Amodio;Umberto Foresta

  • The demonstration of acid α-naphthyl acetate esterase activity in human lymphocytes: Usefulness as a T-cell marker

    D.M. Knowles;T. Hoffman;M. Ferrarini;H.G. Kunkel

  • Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations

    Rajendra N. Damle;Franak M. Batliwalla;Fabio Ghiotto;Angelo Valetto

  • CD38 signaling by agonistic monoclonal antibody prevents apoptosis of human germinal center B cells

    Simona Zupo;Emanuela Rugari;Mariella Dono;Giuseppe Taborelli

  • miR-29b negatively regulates human osteoclastic cell differentiation and function: implications for the treatment of multiple myeloma-related bone disease.

    Marco Rossi;Maria Rita Pitari;Nicola Amodio;Maria Teresa Di Martino

  • Biology and Treatment of Chronic Lymphocytic Leukemia

    Michael J. Keating;Nicholas Chiorazzi;Bradley Messmer;Rajendra N. Damle

Frequent Co-Authors

Antonino Neri
Antonino Neri University of Milan
Nicholas Chiorazzi
Nicholas Chiorazzi Feinstein Institute for Medical Research
Francesco Di Raimondo
Francesco Di Raimondo University of Catania
Luca Agnelli
Luca Agnelli University of Milan
Gianluca Gaidano
Gianluca Gaidano University of Eastern Piedmont Amadeo Avogadro
Vito Pistoia
Vito Pistoia Boston Children's Hospital
Kanti R. Rai
Kanti R. Rai Hofstra University
Robin Foà
Robin Foà Sapienza University of Rome
Massimo Federico
Massimo Federico University of Modena and Reggio Emilia
Pierfrancesco Tassone
Pierfrancesco Tassone Magna Graecia University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare fields can broaden career opportunities. Many professionals pursue advanced nursing roles, particularly in psychiatric and acute care specialties. Online programs have made these options more accessible, allowing students to balance study with professional commitments.

When considering advanced nursing degrees, researching online pmhnp programs with clinical placement is crucial. These programs combine theoretical knowledge with hands-on experience, ensuring graduates are practice-ready. Affordability is another key factor; some institutions offer the cheapest online pmhnp certificate programs that provide quality education without excessive debt.

Many Immunology graduates also consider becoming nurse practitioners, where salaries vary by location. Viewing the dnp salary data helps in making informed decisions about where to study and work. Additionally, those currently practicing as family nurse practitioners might explore transitioning to specialized roles by enrolling in acute care nurse practitioner programs, further expanding their clinical expertise.

Understanding these pathways can provide Immunology students and graduates with valuable insights into complementary career options, supporting long-term professional growth in related medical fields.

Best Scientists Citing Manlio Ferrarini

Trending Scientists